MedTrace Logo

Kinesiophobia in Patients With Chronic Low Back Pain

NCT06190041 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2024-02-22

No results posted yet for this study

Summary

Low back pain is an important health problem that is common in public and causes serious socio-economic losses. Low back pain that persists for more than 12 weeks is defined as chronic low back pain. The prognosis in patients with chronic low back pain is generally not good and it significantly affects the patient's daily living activities and workforce. In the clinical course of chronic low back pain, patients generally reduce some activities or avoid them altogether due to fear of pain or concern about worsening of the initial lesion. This fear is called "kinesiophobia", which is an important factor in the chronicity of low back pain and the resulting functional disabilities. Kinesiophobia causes loss of flexibility, decreased muscle performance, muscle wasting, and all of these lead to a decrease in social and physical activities, which perpetuates and aggravates the disability. The aim of this study is to determine the relationship between the frequency of kinesiophobia in chronic low back pain patients and age, gender, body mass index, educational status, occupation, pain intensity and disability, and to examine the effect of kinesiophobia on quality of life.

Conditions

  • Kinesiophobia
  • Disability
  • Quality of Life

Sponsors & Collaborators

  • Fatih Sultan Mehmet Training and Research Hospital

    lead OTHER

Principal Investigators

  • Yunus Emre Doğan · Fatih Sultan Mehmet Training and Research Hospital

  • Feyza Akan Begoglu · Fatih Sultan Mehmet Training and Research Hospital

  • Gulcan Ozturk · Fatih Sultan Mehmet Training and Research Hospital

  • Meryem Yilmaz Kaysin · Fatih Sultan Mehmet Training and Research Hospital

  • Feyza Unlu Ozkan · Fatih Sultan Mehmet Training and Research Hospital

  • Ilknur Aktas · Fatih Sultan Mehmet Training and Research Hospital

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-10
Primary Completion
2024-04-30
Completion
2024-05-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06190041 on ClinicalTrials.gov